









Markets
/
Stocks
/
nasdaq-scni
/

Scinai Immunotherapeutics Ltd

SCNI

View Detailed Chart

1.470USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

1.25MMarket Cap

0.33P/E TTM



Scinai Immunotherapeutics Ltd

1.470

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

+0.68%

5 Days

-28.64%

1 Month

-33.27%

6 Months

-58.23%

Year to Date

-56.05%

1 Year

-62.02%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(0)

Buy(0)

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.146

Sell

RSI(14)

24.680

Sell

STOCH(KDJ)(9,3,3)

3.806

Oversold

ATR(14)

0.263

High Vlolatility

CCI(14)

-172.559

Sell

Williams %R

96.635

Oversold

TRIX(12,20)

-0.900

Sell

StochRSI(14)

3.704

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.718

Sell

MA10

1.957

Sell

MA20

2.094

Sell

MA50

2.332

Sell

MA100

2.537

Sell

MA200

2.985

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.

Ticker SymbolSCNI

CompanyScinai Immunotherapeutics Ltd

CEOMr. Amir Reichman

Websitehttps://www.scinai.com/